IsoPlexis to Participate in Upcoming Investor Conferences

Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO) announced its participation in two upcoming investor conferences focused on health and diagnostics. The first event is the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on November 17 at 1:00 p.m. ET, featuring a Multi-Omics Panel. The second event is the Evercore ISI HealthCONx Conference, held virtually on December 1 at 12:10 p.m. ET, including a fireside chat. A webcast of the latter will be accessible on the company's website.

BRANFORD, Conn., Nov. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the following investor conferences.

• Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, New York, NY
  Multi-Omics Panel on Thursday, November 17^th at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time

• Evercore ISI HealthCONx Conference, Virtual
  Fireside Chat on Thursday, December 1^st at 12:10 p.m. Eastern Time / 9:10 a.m. Pacific Time

A live webcast and replay of the Evercore ISI HealthCONx Conference fireside chat will be available on the “Investors” section of the company website at: www.isoplexis.com.

About IsoPlexis

IsoPlexis is empowering labs to leverage the cells and proteome changing the course of human health. Its platforms provide insights into how multi-functional immune cells communicate and respond, assisting researchers in understanding and predicting disease progression, treatment resistance and therapeutic efficacy.

IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies by revenue and 78% of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com

FAQ

What conferences is IsoPlexis Corporation participating in for November 2022?

IsoPlexis is participating in the Canaccord Genuity MedTech Forum on November 17 and the Evercore ISI HealthCONx Conference on December 1.

When is the Multi-Omics Panel for IsoPlexis at the Canaccord Genuity Forum?

The Multi-Omics Panel for IsoPlexis at the Canaccord Genuity Forum is scheduled for November 17 at 1:00 p.m. Eastern Time.

Where can I watch the Evercore ISI HealthCONx Conference fireside chat featuring IsoPlexis?

The fireside chat at the Evercore ISI HealthCONx Conference will be available via live webcast on the Investors section of IsoPlexis' website.

What is IsoPlexis known for in the biotechnology sector?

IsoPlexis is recognized for its innovative platforms that help researchers understand immune cell responses and disease progression.

Who are the key users of IsoPlexis technology?

IsoPlexis technology is utilized by top global pharmaceutical companies and 78% of leading U.S. comprehensive cancer centers.